The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACADIA PHARMACEUTICALS INC | Common | 004225108 | 56,039 | 1,630,000 | SH | SOLE | 1,630,000 | 0 | 0 | ||
| AERIE PHARMACEUTICALS INC | Common | 00771V108 | 19,274 | 425,000 | SH | SOLE | 425,000 | 0 | 0 | ||
| AGENUS INC | Common | 00847G705 | 12,700 | 3,368,828 | SH | SOLE | 3,368,828 | 0 | 0 | ||
| AKEBIA THERAPEUTICS INC | Common | 00972D105 | 4,199 | 456,369 | SH | SOLE | 456,369 | 0 | 0 | ||
| ALIMERA SCIENCES INC | Common | 016259103 | 8,108 | 5,791,581 | SH | SOLE | 5,791,581 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | Common | 03152W109 | 34,563 | 4,847,577 | SH | SOLE | 4,847,577 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | Common | 03152W109 | 206 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | |
| ARRAY BIOPHARMA INC | Common | 04269X105 | 33,793 | 3,780,000 | SH | SOLE | 3,780,000 | 0 | 0 | ||
| ARRAY BIOPHARMA INC | Common | 04269X105 | 121 | 161,400 | SH | Call | SOLE | 161,400 | 0 | 0 | |
| ARRAY BIOPHARMA INC | Common | 04269X105 | 120 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | |
| ARRAY BIOPHARMA INC | Common | 04269X105 | 149 | 400,000 | SH | Call | SOLE | 400,000 | 0 | 0 | |
| ASCENDIS PHARMA | Sponsored ADR | 04351P101 | 19,626 | 700,924 | SH | SOLE | 700,924 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | Common | 045396108 | 17,751 | 696,409 | SH | SOLE | 696,409 | 0 | 0 | ||
| AVEO PHARMACEUTICALS INC | Common | 053588109 | 2,323 | 3,938,030 | SH | SOLE | 3,938,030 | 0 | 0 | ||
| AVEXIS INC | Common | 05366U100 | 17,135 | 225,370 | SH | SOLE | 225,370 | 0 | 0 | ||
| AXOVANT SCIENCES LTD | Common | G0750W104 | 5,746 | 384,587 | SH | SOLE | 384,587 | 0 | 0 | ||
| BELLICUM PHARMACEUTICALS INC | Common | 079481107 | 1,543 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| BIOCRYST PHARMACEUTICALS INC | Common | 09058V103 | 13,465 | 1,603,001 | SH | SOLE | 1,603,001 | 0 | 0 | ||
| BIOMARIN PHARMACEUTICAL INC | Common | 09061G101 | 51,790 | 590,000 | SH | SOLE | 590,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | Common | 09627Y109 | 6,598 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | ||
| CASCADIAN THERAPEUTICS INC | Common | 14740B606 | 7,540 | 1,821,248 | SH | SOLE | 1,821,248 | 0 | 0 | ||
| CATALYST PHARMACEUTICALS INC | Common | 14888U101 | 7,419 | 3,804,745 | SH | SOLE | 3,804,745 | 0 | 0 | ||
| CELLECTIS - ADR | Sponsored ADR | 15117K103 | 2,330 | 97,096 | SH | SOLE | 97,096 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | Common | 189464100 | 22,533 | 353,900 | SH | SOLE | 353,900 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | Common | 189464100 | 258 | 125,800 | SH | Call | SOLE | 125,800 | 0 | 0 | |
| CORVUS PHARMACEUTICALS INC | Common | 221015100 | 2,528 | 121,715 | SH | SOLE | 121,715 | 0 | 0 | ||
| DERMIRA INC | Common | 24983L104 | 41,011 | 1,202,313 | SH | SOLE | 1,202,313 | 0 | 0 | ||
| FORTRESS BIOTECH INC | Common | 34960Q109 | 3,688 | 996,663 | SH | SOLE | 996,663 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS INC | Common | 37890U108 | 30,033 | 815,000 | SH | SOLE | 815,000 | 0 | 0 | ||
| IMMUNOMEDICS INC | Common | 452907108 | 67,858 | 10,488,076 | SH | SOLE | 10,488,076 | 0 | 0 | ||
| LION BIOTECHNOLOGIES INC | Common | 53619R102 | 33,908 | 4,551,343 | SH | SOLE | 4,551,343 | 0 | 0 | ||
| MEDICINES CO | Common | 584688105 | 57,947 | 1,185,000 | SH | SOLE | 1,185,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | Common | 60468T105 | 12,393 | 2,383,201 | SH | SOLE | 2,383,201 | 0 | 0 | ||
| NEURODERM LTD | Common | M74231107 | 15,665 | 590,000 | SH | SOLE | 590,000 | 0 | 0 | ||
| ONCOBIOLOGICS INC | Common | 68235M105 | 1,832 | 683,531 | SH | SOLE | 683,531 | 0 | 0 | ||
| ONCOBIOLOGICS INC - WARRANT A | Warrant | 68235M113 | 187 | 233,333 | SH | SOLE | 233,333 | 0 | 0 | ||
| ONCOBIOLOGICS INC - WARRANT B | Warrant | 68235M121 | 117 | 233,333 | SH | SOLE | 233,333 | 0 | 0 | ||
| PACIRA PHARMACEUTICALS INC | Common | 695127100 | 18,696 | 410,000 | SH | SOLE | 410,000 | 0 | 0 | ||
| PERNIX THERAPEUTICS HOLDINGS INC | Convertible Debt | 71426VAK4 | 1,651 | 6,000,000 | PRN | SOLE | 6,000,000 | 0 | 0 | ||
| SEATTLE GENETICS INC | Common | 812578102 | 28,287 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
| SORRENTO THERAPEUTICS INC | Common | 83587F202 | 4,709 | 1,192,130 | SH | SOLE | 1,192,130 | 0 | 0 | ||
| TELIGENT INC | Common | 87960W104 | 29,612 | 3,791,512 | SH | SOLE | 3,791,512 | 0 | 0 | ||
| TESARO INC | Common | 881569107 | 63,367 | 411,823 | SH | SOLE | 411,823 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | Common | 89620X506 | 1,399 | 227,399 | SH | SOLE | 227,399 | 0 | 0 | ||
| VANDA PHARMACEUTICALS INC | Common | 921659108 | 8,641 | 617,200 | SH | SOLE | 617,200 | 0 | 0 | ||
| VERACYTE INC | Common | 92337F107 | 8,326 | 906,999 | SH | SOLE | 906,999 | 0 | 0 | ||
| VIVEVE MEDICAL INC | Common | 92852W204 | 5,634 | 890,000 | SH | SOLE | 890,000 | 0 | 0 | ||